302 related articles for article (PubMed ID: 34022456)
1. CD8
Monteiro AC; Bonomo A
Bone; 2021 Sep; 150():116014. PubMed ID: 34022456
[TBL] [Abstract][Full Text] [Related]
2. Cooperation between T and B cells reinforce the establishment of bone metastases in a mouse model of breast cancer.
Monteiro AC; de Andrade Garcia D; Du Rocher B; Fontão APGA; Nogueira LP; Fidalgo G; Colaço MV; Bonomo A
Bone; 2024 Jan; 178():116932. PubMed ID: 37832903
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells development into osteoclast-type APCs by 4T1 breast tumor T cells milieu boost bone consumption.
Monteiro AC; Bonomo A
Bone; 2021 Feb; 143():115755. PubMed ID: 33217627
[TBL] [Abstract][Full Text] [Related]
4. Metformin Reduces Thyroid Cancer Tumor Growth in the Metastatic Niche of Bone by Inhibiting Osteoblastic RANKL Productions.
Shin HS; Sun HJ; Whang YM; Park YJ; Park DJ; Cho SW
Thyroid; 2021 May; 31(5):760-771. PubMed ID: 32791889
[No Abstract] [Full Text] [Related]
5. T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer.
Monteiro AC; Leal AC; Gonçalves-Silva T; Mercadante AC; Kestelman F; Chaves SB; Azevedo RB; Monteiro JP; Bonomo A
PLoS One; 2013; 8(7):e68171. PubMed ID: 23935856
[TBL] [Abstract][Full Text] [Related]
6. Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms.
Lee JH; Kim B; Jin WJ; Kim JW; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2014 Sep; 91(1):51-60. PubMed ID: 24929117
[TBL] [Abstract][Full Text] [Related]
7. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.
Kolb AD; Shupp AB; Mukhopadhyay D; Marini FC; Bussard KM
Breast Cancer Res; 2019 Feb; 21(1):31. PubMed ID: 30813947
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells.
Yuan X; Qian N; Ling S; Li Y; Sun W; Li J; Du R; Zhong G; Liu C; Yu G; Cao D; Liu Z; Wang Y; Qi Z; Yao Y; Wang F; Liu J; Hao S; Jin X; Zhao Y; Xue J; Zhao D; Gao X; Liang S; Li Y; Song J; Yu S; Li Y
Theranostics; 2021; 11(3):1429-1445. PubMed ID: 33391543
[No Abstract] [Full Text] [Related]
9. Osteoclast-Primed Foxp3+ CD8 T Cells Induce T-bet, Eomesodermin, and IFN-γ To Regulate Bone Resorption.
Shashkova EV; Trivedi J; Cline-Smith AB; Ferris C; Buchwald ZS; Gibbs J; Novack D; Aurora R
J Immunol; 2016 Aug; 197(3):726-35. PubMed ID: 27324129
[TBL] [Abstract][Full Text] [Related]
10. Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase.
Fong JE; Le Nihouannen D; Komarova SV
J Biol Chem; 2010 Oct; 285(41):31427-34. PubMed ID: 20679341
[TBL] [Abstract][Full Text] [Related]
11. Bone Microenvironment-Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice.
Arellano DL; Juárez P; Verdugo-Meza A; Almeida-Luna PS; Corral-Avila JA; Drescher F; Olvera F; Jiménez S; Elzey BD; Guise TA; Fournier PGJ
J Bone Miner Res; 2022 Aug; 37(8):1446-1463. PubMed ID: 35635377
[TBL] [Abstract][Full Text] [Related]
12. [Vascular endothelial growth factor secreted by breast cancer cells plays a critical role in the formation of pre-metastatic niche in the mouse lung].
Li R; Yuan B; Zhang Y; Dai J; Zhang P; Fang F; Han M
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):17-22. PubMed ID: 26796801
[TBL] [Abstract][Full Text] [Related]
13. LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients.
Brunetti G; Belisario DC; Bortolotti S; Storlino G; Colaianni G; Faienza MF; Sanesi L; Alliod V; Buffoni L; Centini E; Voena C; Pulito R; Novello S; Ingravallo G; Rizzi R; Mori G; Reseland JE; Ware CF; Colucci S; Ferracini R; Grano M; Roato I
J Bone Miner Res; 2020 Apr; 35(4):671-680. PubMed ID: 31826304
[TBL] [Abstract][Full Text] [Related]
14. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
15. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.
Canon J; Bryant R; Roudier M; Branstetter DG; Dougall WC
Breast Cancer Res Treat; 2012 Oct; 135(3):771-80. PubMed ID: 22926264
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment.
Haider MT; Saito H; Zarrer J; Uzhunnumpuram K; Nagarajan S; Kari V; Horn-Glander M; Werner S; Hesse E; Taipaleenmäki H
Breast Cancer Res; 2020 Apr; 22(1):34. PubMed ID: 32272947
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
18. miR-92a-3p encapsulated in bone metastatic mammary tumor cell-derived extracellular vesicles modulates mature osteoclast longevity.
Uehara N; Kyumoto-Nakamura Y; Mikami Y; Hayatsu M; Sonoda S; Yamaza T; Kukita A; Kukita T
Cancer Sci; 2022 Dec; 113(12):4219-4229. PubMed ID: 36053115
[TBL] [Abstract][Full Text] [Related]
19. Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis.
Logan JG; Sophocleous A; Marino S; Muir M; Brunton VG; Idris AI
J Bone Miner Res; 2013 May; 28(5):1229-42. PubMed ID: 23239200
[TBL] [Abstract][Full Text] [Related]
20. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
Hashimoto K; Ochi H; Sunamura S; Kosaka N; Mabuchi Y; Fukuda T; Yao K; Kanda H; Ae K; Okawa A; Akazawa C; Ochiya T; Futakuchi M; Takeda S; Sato S
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2204-2209. PubMed ID: 29440427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
